Dublin, July 31, 2024 (GLOBE NEWSWIRE) — The “Downstream Processing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F” report has been added to ResearchAndMarkets.com’s offering.
The global downstream processing market has showcased a robust growth trajectory, valued at USD 31.23 Billion in 2023. Industry projections indicate a continued upward trend, with an impressive compounded annual growth rate (CAGR) of 6.52% expected through 2029.
This market encompasses the critical stage of purifying and separating biopharmaceutical and bio-based products after initial production, a process essential for ensuring the high purity and potency of these products.
Key drivers influencing this exceptional growth include a soaring demand for biopharmaceuticals, technological innovations in processing methods, and expansion of biopharmaceutical production facilities. The pursuit of advanced healthcare solutions has positioned biopharmaceuticals such as vaccines and monoclonal antibodies at the forefront of personalized medicine, thereby amplifying the need for sophisticated downstream processes.
In parallel, technological advancements such as single-use systems and high-throughput screening techniques are optimizing purification processes and facilitating efficiency and cost-effectiveness across the board. Coupled with the expansion of biopharmaceutical production facilities worldwide, these innovations have contributed to a substantial increase in the market’s capacity to meet growing demands.
Addressing Market Challenges
Despite the optimistic growth outlook, the downstream processing market faces challenges including cost pressures, the complexity of processes, and scalability concerns. Innovations in chromatography systems, targeted approaches to single-use systems, and the integration of automation and digitalization are seen as pivotal strategies to overcome these hurdles, ensuring sustainability and excellence in the biopharmaceutical production landscape.
Geographical and Segmental Market Analysis
Regionally, North America has emerged as a leader in the global downstream processing market, attributed to government support for bioprocess technology, robust healthcare infrastructure, and significant R&D investments. By product, chromatography systems are at the helm of the market, driven by ongoing advancements and the critical role they play in purifying complex biomolecules. Technique-wise, purification through chromatography has been the dominant force, catering to the standard of precision required in biopharmaceuticals’ separation and purification.
The global downstream processing market is a crucial component of the biopharmaceutical industry. As the market braces for further growth and innovation, its role in delivering safe, effective, and accessible treatments worldwide remains indisputably critical.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 185 |
| Forecast Period | 2023 – 2029 |
| Estimated Market Value (USD) in 2023 | $31.05 Billion |
| Forecasted Market Value (USD) by 2029 | $49.14 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes, but is not limited to:
- Merck KGaA
- Sartorius AG
- GE HealthCare Technologies Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- 3M Company
- Boehringer Ingelheim International GmbH
- Corning Incorporated
- Lonza Group Ltd
- Dover Corporation
For more information about this report visit https://www.researchandmarkets.com/r/wfov5s
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Downstream Processing Market
